Eligibility for mechanical circulatory support devices based on current and past randomised cardiogenic shock trials [PDF]
European Journal of Heart Failure, 2021 Mechanical circulatory support devices (MCS) are potentially effective treatments for cardiogenic shock (CS) and are thus evaluated in several randomised controlled trials (RCTs).
Benedikt Schrage +16 more
openalex +2 more sources
Association between Public Reporting of Outcomes and the Use of Mechanical Circulatory Support in Patients with Cardiogenic Shock [PDF]
Journal of Interventional Cardiology, 2019 Risk-averse behavior has been reported among physicians and facilities treating cardiogenic shock in states with public reporting. Our objective was to evaluate if public reporting leads to a lower use of mechanical circulatory support in cardiogenic ...
Vikas Singh +7 more
doaj +2 more sources
The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety [PDF]
F1000Research, 2020 Acute mechanical circulatory support (MCS) devices are widely used in cardiogenic shock (CS) despite a lack of high-quality clinical evidence to guide their use.
Navin K. Kapur +3 more
openalex +2 more sources
Case Report: Maternal near-miss—recovery from refractory septic shock with multiple organ dysfunction secondary to acute pyelonephritis in pregnancy [PDF]
Frontiers in MedicineBackgroundUrinary tract infections during pregnancy represent a significant clinical concern, posing considerable risks to both maternal and fetal health. The physiological changes associated with pregnancy increase the susceptibility to infections, with
Hong Chen +5 more
doaj +2 more sources
Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP/5.0 versus ECMO [PDF]
European heart journal. Acute cardiovascular care, 2019 Background: Short-term mechanical circulatory support devices are increasingly used in cardiogenic shock after acute myocardial infarction. As no randomised evidence is available, the choice between high-output Impella or extra-corporeal membrane ...
Mina Karami +9 more
openalex +2 more sources
Clinical review: Circulatory shock - an update: a tribute to Professor Max Harry Weil [PDF]
, 2012 Circulatory shock is common and associated with high morbidity and mortality. Appropriate shock treatment relies on a good understanding of the pathophysiological mechanisms underlying shock.
Bakker, J. (Jan) +2 more
core +17 more sources
Circulatory Shock among Hospitalized Patients for Salicylate Intoxication
Diseases, 2021 Background: This study aimed to evaluate the risk factors for circulatory shock and its impact on outcomes in patients hospitalized for salicylate intoxication.
Tananchai Petnak +9 more
doaj +1 more source
Pediatric Emergency Medicine Journal, 2020 Cardiogenic shock is an acute circulatory failure due to compromised myocardial contractility associated with congenital heart diseases and cardiomyopathies, such as myocarditis. In this article, the authors present a 3-step overview of cardiogenic shock
Sungkyu Cho, Sang-Yun Lee
doaj +1 more source
Use of mechanical circulatory support in patients with non‐ischaemic cardiogenic shock
European Journal of Heart Failure, 2023 Despite its high incidence and mortality risk, there is no evidence‐based treatment for non‐ischaemic cardiogenic shock (CS). The aim of this study was to evaluate the use of mechanical circulatory support (MCS) for non‐ischaemic CS treatment.
B. Schrage +42 more
semanticscholar +1 more source
JACC: Case Reports, 2023 Patients with advanced cardiogenic shock requiring mechanical circulatory support are uniquely susceptible to clinical deterioration. Limiting physiologic perturbations via avoidance of general anesthesia and endotracheal intubation by awake Impella 5.5 ...
John DePaolo, MD, PhD +9 more
doaj +1 more source